US Stock MarketDetailed Quotes

DSGN Design Therapeutics

Watchlist
  • 4.570
  • -0.200-4.19%
Close May 10 16:00 ET
  • 4.520
  • -0.050-1.09%
Post 19:51 ET
258.18MMarket Cap-4394P/E (TTM)

Design Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Design Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-0.20

+42.86%
Analyst Rating

Buy

May 7, 2024

Design Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
Mar 19, 20242023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
--2023/Q20.000 / 0.000--
--2023/Q10.000 / 0.000--
--2022/Q40.000 / 0.000--
--2022/Q30.000 / 0.000--
--2022/Q20.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
Mar 19, 20242023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
--2023/Q20.000 / 0.000--
--2023/Q10.000 / 0.000--
--2022/Q40.000 / 0.000--
--2022/Q30.000 / 0.000--
--2022/Q20.000 / 0.000--

Unlock Free Earnings Estimates

Design Therapeutics Earnings Reports

  • Design Therapeutics | 10-Q: Quarterly report

    May 8 16:55 ET

  • Design Therapeutics | 10-K: Annual report

    Mar 19 16:23 ET

  • Design Therapeutics: Q3 2023 Earnings Report

    Nov 13, 2023 16:14 ET

  • Design Therapeutics | 10-Q: Q2 2023 Earnings Report

    Aug 14, 2023 16:11 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: May 7, 2024

    Buy

    • Buy

      25.00%

    • Hold

      75.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg